Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies
Clinical trial NCT04305249 · TERMINATED
Trial details
- NCT number
- NCT04305249
- Sponsor
- Antengene Therapeutics Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-15
- Primary completion
- 2024-04-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.